Every story in this section, newest first — page 304 of 373.
Heritage Financial (NASDAQ:HFWA) announced Monday that it has finalized its acquisition of Olympic Bancorp, a move that creates one of the most significant community banking platforms in the Pacific Northwest.
TuHURA Biosciences (NASDAQ:HURA) announced Monday that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its lead immune-priming candidate, IFx-2.0, for the treatment of stage IIB to stage IV cutaneous melanoma.
TransUnion (NYSE:TRU) signed a definitive agreement on Monday to acquire the mobile division of RealNetworks, a move aimed at integrating advanced artificial intelligence and machine learning into its growing communications and fraud-prevention suite.
Huntington Bancshares (NASDAQ:HBAN) completed its merger with Cadence Bank on Monday, creating a $279 billion regional powerhouse and marking one of the most significant consolidations in the U.S. banking sector this year.
Stoneridge (NYSE SRI) finalized the sale of its Control Devices segment to an affiliate of Center Rock Capital Partners on Friday, marking a definitive shift toward its high-growth electronics and safety platforms.
Ermenegildo Zegna (NYSE:ZGN) reported preliminary fiscal year 2025 revenues of €1.92 billion on Monday, as the Italian luxury group successfully leveraged its direct-to-consumer (DTC) strategy to offset a challenging wholesale environment and persistent volatility in China.
Alliance Resource Partners (NASDAQ:ARLP) reported a massive surge in fourth-quarter profitability on Monday, as record oil and gas royalty volumes and improved coal operational efficiency drove a triple-digit increase in net income.
Opera (NASDAQ:OPRA) announced on Monday that its fourth-quarter and full-year 2025 performance is expected to significantly exceed its prior financial targets.
NAPCO Security Technologies (NASDAQ:NSSC) reported record fiscal second-quarter results on Monday, as the company’s high-margin recurring services business continued to reshape its profitability profile.
Tyson Foods (NYSE:TSN) reported a 5.1% increase in first-quarter revenue to $14.31 billion, surpassing Wall Street expectations as the meat giant’s diversified portfolio helped mitigate ongoing headwinds in its beef segment.
ESAB (NYSE:ESAB) announced on Monday a definitive agreement to acquire Eddyfi Technologies for $1.45 billion, marking a significant strategic pivot into the advanced non-destructive testing (NDT) and structural integrity market.
Eton Pharmaceuticals (NASDAQ:ETON) announced on Monday that it has secured U.S. marketing rights for a new ultra-rare disease product candidate, further cementing its position in the specialized orphan drug market.
Dublin-based Aptiv (NYSE:APTV), a global technology company focused on enabling a more automated, electrified, and digitalized future, today reported record financial results for the fourth quarter and full year ended December 31, 2025.
Fifth Third Bancorp (NASDAQ:FITB) finalized its merger with Comerica Incorporated on Monday, creating a regional banking powerhouse with approximately $294 billion in assets.
IDEXX Laboratories (NASDAQ:IDXX) reported fourth-quarter earnings that surpassed analyst expectations, fueled by double-digit growth in its core companion animal business and significant margin expansion.
FEMSA (NYSE:FMX) finalized the separation of its Grupo Nós joint venture with Raízen on Monday, resulting in FEMSA assuming 100% ownership of OXXO Brazil.
Natera (NASDAQ:NTRA) submitted a formal application for U.S. regulatory approval of its Signatera molecular residual disease test as a companion diagnostic for bladder cancer, moving to solidify its lead in the burgeoning field of precision oncology.
Revvity (NYSE:RVTY) reported fourth-quarter and full-year 2025 results on Monday that exceeded Wall Street estimates, bolstered by resilient demand across its life sciences and diagnostics portfolios.
Patria Investments (NASDAQ:PAX) reached a deal to acquire WP Global Partners on Monday, a move that significantly bolsters the firm’s presence in the U.S. lower-middle market.
Arthur J. Gallagher (NYSE:AJG) bolstered its international risk management division on Monday, announcing that its subsidiary Gallagher Bassett has acquired Bremen, Germany-based Reck & Co. GmbH.
Mizuho Financial Group (NYSE:MFG) reported fiscal third-quarter earnings that surpassed Wall Street expectations, as Japan’s third-largest lender benefited from a favorable interest rate environment and steady corporate lending activity.
Alvotech (NASDAQ:ALVO) solidified its global commercialization strategy on Monday, entering into new supply and marketing agreements with Sandoz to bring a suite of biosimilar candidates to Canada, Australia, and New Zealand.
Li Auto (NASDAQ:LI) reported a cooling in delivery momentum to start 2026, as the Beijing-based automaker delivered 27,668 vehicles in January.
NIO (NYSE:NIO) accelerated into 2026 with a 96.1% year-over-year surge in January deliveries, a performance that officially pushed the Chinese electric vehicle maker past the one-million cumulative delivery mark.
